DrugDashboards

Market view

levothyroxine sodium anhydrous · Injection, Powder, Lyophilized, For Solution

19 marketed package NDCs · 6 active manufacturers

Most dispensed: 100 ug/5mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 5 ml in 1 vial, single-dose · 500 ug/5mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 5 ml in 1 vial, single-dose · 200 ug/5mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 5 ml in 1 vial, single-dose

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble.

Same drug class

Other molecules FDA puts in l-Thyroxine, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Levothyroxine sodium anhydrous in shortage right now?
No. FDA does not currently list Levothyroxine sodium anhydrous in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Levothyroxine sodium anhydrous?
6 companies have marketed Levothyroxine sodium anhydrous in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.